Analysts think CRBP stock price could increase by 278%
Sep 25, 2024, 6:26 AM
-9.43%
What does CRBP do
Corbus Pharmaceuticals, based in Norwood, Massachusetts, focuses on developing therapies for rare inflammatory diseases and cancer, with a pipeline including CRB-701 and CRB-601. The company went public on October 24, 2014, and employs 19 staff.
10 analysts think CRBP stock price will increase by 278.19%. The current median analyst target is $69.36 compared to a current stock price of $18.34. The lowest analysts target is $40.40 and the highest analyst target is $110.25.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
